



Millions of children die of shock due to various etiologies each year. Shock is a state of circulatory dysfunction where 
the metabolic demands of the tissue cannot be met by the circulation. Several different etiologies from hypovolemia to 
severe infection can result in shock. This review focuses on the definition of different types of shock seen in children and 
summarizes treatment strategies for the acute care practitioner based on pertinent recent literature.  Early recognition and 
timely intervention are critical for successful treatment of pediatric shock. A strong index of suspicion by the treating clinician 
and early fluid resuscitation followed by ongoing assessment and timely transfer to a higher level of care can make the 
difference between life and death for the child who presents in shock. 
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Introduction 
More than 10 million children die each 
year in the world. The highest mortality 
rates are observed in children under 
five years in developing countries. 
Shock is the result of various etiologies 
and the leading causes of shock in 
children younger than 5 years of age 
are: pneumonia (19 %), diarrhea (18 
%), malaria (8 %), neonatal pneumo-
nia or sepsis (10 %), preterm delivery 
(10 %), and asphyxia at birth (8 %). (1) 
The early recognition of signs of shock 
and aggressive therapy to restore the 
intravascular volume and reverse the 
biochemical cascade is believed to 
improve outcome.
Pathophysiology
Shock ensues when systemic oxygen 
and nutrient supply become acutely 
inadequate to meet the metabolic 
demands of the body’s organ systems. 
The true incidence of pediatric shock 
is not well documented in the litera-
ture. The most common cause of shock 
seen in pediatric patients is hypovo-
lemic shock secondary dehydration.
The primary function of the cardiovas-
cular system is to provide oxygen and 
other substrates to the cells as illus-
trated in figure 1. Oxygen content is 
defined as the total oxygen in whole 
blood and available to tissues. Oxygen 
content is an important consideration in 
the physiologic management of critical-
ly ill patients. Oxygen exists in two forms 
in the blood, dissolved and hemoglobin 
bound.  The majority of oxygen stored 
in whole blood is bound to hemoglob-
in. The oxygen saturation (O2 sats) is 
dependent on oxygen tension. 
Cardiac output is the product of stroke 
volume and heart rate, stroke volume in 
turn is determined by ventricular filling 
volume and pressure (preload), myo-
cardial contractility and the impedance 
to left ventricular output along with sys-
temic vascular resistance (afterload).
In healthy individuals the oxygen con-
sumption and demand are equal. 
Mixed venous oxygen saturations or 
central venous oxygen saturation can 
help to determine whether the cardi-
Figure 1. Role of cardiovascular system in oxygen delivery.
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ac output and oxygen delivery is high 
enough to meet a patient’s needs. The 
determinants of mixed venous oxygen 
saturation (SvO2) include cardiac out-
put, oxygen demand, hemoglobin level 
and arterial saturation. Normal SvO2 is 
5-7 % lower than central venous oxygen 
saturation. Any condition that disrupts 
this equilibrium and decreases oxygen 
delivery or increases oxygen demand 
may result in shock.
More explicitly, shock may be a conse-
quence of several catastrophic condi-
tions such as: 1) decreased blood oxy-
gen carrying capacity with acute and 
profound decrease in hemoglobin (e.g. 
hemorrhagic shock, rapid hemolysis), 
2) unavailability of oxygen with resulting 
severe hypoxemia (e.g. suffocation, CO 
poisoning) or 3) pumping or “plumb-
ing” failure causing severe hypoper-
fusion or ischemia (e.g. cardiogenic 
and  distributive shock, respectively). 
Depending on the underlying mecha-
nism, tissue hypoxemia could be abso-
lute as in hemorrhagic shock where 
supply is inadequate or relative as in 
septic shock where increasing demand 
cannot be met. Deprivation of tissues 
from oxygen leads to inadequate ATP 
production. In the absence of adequate 
oxygen, cells will revert to anaerobic 
metabolism which is almost 20-fold 
less efficient in terms of energy produc-
tion compared to aerobic metabolism 
(2 ATP molecules produced anaerobi-
cally from 1 molecule of glucose vs. 36 
ATPs produced aerobically). Anaerobic 
metabolism also produces large quanti-
ties of pyruvate which will be converted 
into lactate; prolonged hypoperfusion 
will lead to a build-up of hydrogen ions 
from lactic acid with ensuing metabolic 
acidosis. Circulatory insufficiency will 
also lead to a build-up of toxic metabo-
lites that cannot be cleared away, con-
tributing to microcirculatory dysfunc-
tion. Different types of shock meet in the 
final common pathway of tissue hypox-
emia and energy uncoupling ultimately 
leading to death first at the cellular level 
as apoptosis and necrosis than leading 
to organ dysfunction and ultimately to 
demise of the patient. (2,3)
Shock is a dynamic process and pro-
gresses if not recognized and treated in 
a timely fashion. As the stage of shock 
increases so does mortality, with mor-
tality rates increasing to over 10-fold in 
severe shock compared to early occult 
shock. (4) Since compensatory mecha-
nisms may mask signs of tissue hypop-
erfusion especially in the young host, 
recognition in the early “cryptic” stages 
requires a high index of suspicion. Even 
with normal blood pressure, low car-
diac index and low mixed venous pO2 
predict death from shock. (5,6) It is 
necessary to diagnose tissue hypoper-
fusion early to implement appropriate 
intervention.
Stages of shock
Early or Compensated 
Shock
In early compensated shock several 
compensatory mechanism are acti-
vated. In the face of impending hypop-
erfusion, sympathetic nervous system 
stimulation increases heart rate and 
systemic vascular resistance (SVR) 
through the release of catecholamines 
from adrenal glands. Renin-angi-
otensin-aldosterone system is also acti-
vated, contributing to vasoconstriction, 
maintenance of SVR, and fluid retention 
through concentration of urine. 
In children, vascular tone is maintained 
in low flow states  (7) of septic and car-
diogenic shock. Therefore, children can 
often maintain their blood pressure until 
they are in profound shock. Compensa-
tory vasoconstriction is often so pro-
nounced that systemic blood pressure 
can be maintained within the normal 
range despite significant circulatory com-
promise. Hypotension is typically a late 
finding among children in shock. With 
vasoconstriction, blood flow is shunted 
away from the non-vital organs (skin 
and splanchnic bed) to brain, heart, and 
lungs. As a result, extremities are cold 
and mottled, capillary refill is prolonged, 
catecholamine-induced tachycardia 
occurs.  If shock is left untreated, the 
compensatory mechanisms will fail and 
uncompensated shock develops. Fail-
ure of normalization of peripheral pulses, 
skin temp, and capillary refill with treat-
ment predicts death from shock. (6)
Children are mostly dependent on 
their heart rate to increase cardiac out-
put. Ability to increase contractility in 
response to catecholamine stimula-
tion is limited due to insufficient muscle 
mass and “stiffness” of the young myo-
cardium compared to the adult heart. (8) 
When the compensatory mechanisms 
are activated children become depend-
ent on intravascular volume (preload) 
to maintain CO. (9) Since afterload is 
already increased in an effort to main-
tain SVR and BP, maintaining adequate 
intravascular volume is the key aspect 
of successful resuscitation.
Uncompensated shock 
When the compensatory mechanisms 
fail to meet the increased metabolic 
demands at the tissue level uncom-
pensated shock with hypotension 
will develop. Tissue hypoxemia and 
ischemia will trigger anaerobic metabo-
lism resulting in lactate build-up and the 
development of metabolic acidosis. A 
number of other vasoactive metabo-
lites such as adenosine, nitric oxide are 
also released and accumulate locally. 
Compensatory vasoconstriction fails as 
a result of hypoxia. Capillary blood flow 
becomes sluggish, leukocytes mar-
ginate, microthrombi form. The vaso-
motor paralysis and   microcirculatory 
dysfunction escalate into end-organ 
hypoperfusion, organ dysfunction, and 
multi-organ failure. Organ hypoper-
fusion manifests itself as early organ 
dysfunction with altered mental sta-
tus, tachypnea, tachycardia, lethargy, 
decreased or absent urine output, and 
mottled extremities. Once the blood 
pressure falls, the patient will progress 
into irreversible shock if the perfusion 
pressure to tissues is not restored. Irre-
versible shock, as the name implies, is 
the point of no return when the mortal-
ity rate is high irrespective of interven-
tions. 
Types of Shock
Several types of shock syndrome can 
be recognized based on the etiology. 
Table 1 summarizes the types of shock 
seen in pediatric patients and below is 
a brief description of each type.
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Type of shock
Mechanism of circulatory 
failure Signs and symptoms Interventions
Hypovolemic
Volume depletion absolute or 
relative, CO ↓, SVR ↑
Tachycardia, diminished 
pulses, sunken eyes and 
fontanels, oliguria, prolonged 
cap refill time
Crystalloid bolus 20 ml/kg 
until hemodynamics improve, 
reassess after each bolus, 
blood products in hemorrhagic 
shock
Cardiogenic CO ↓, SVR ↑
Tachycardia, diminished 
pulses, hepatomegaly, JVD
Inotropic agents dopamine, 
dobutamine, epinephrine, 
milrinone
Small volume boluses 5-10 
ml/kg might be administered 
carefully while monitoring 
response
Get echo early 
Distributive
        Anaphylactic
        
      Neurogenic
CO ↑, then ↓, SVR ↓↓
Angioedema, respiratory 
distress, stridor, wheezing, 
early hypotension
Start adrenergic support while 
giving fluids, obtain vascular 
access early, supratherapeutic 
doses of inotropes might be 
required
CO normal, SVR ↓
Hypotension in the absence of 
tachycardia
Support SVR with 
vasopressors, phenylephrine 
might be required, give fluids 
as necessary
      Septic
“Warm shock” CO ↑, SVR↓ 
(20% of pediatric cases)
Tachycardia, bounding 
pulses, warm extremities with 
hypotension, hyperpnoea, 
altered mentation
Crytalloid boluses of 20 ml/kg 
repeat until hemodynamics 
stable, first choice agents 
vasopressors (dopamine or 
norepinephrine)
“Cold shock” CO ↓, SVR ↑
(60% of pediatric cases)
Tachycardia, poor peripheral 
perfusion, diminished 
pulses, hyperpnoea, altered 
mentation
Crytalloid boluses of 20 ml/kg 
repeat until hemodynamics 
stable, early inotropic 
support with dopamine or 
epinephrine might be required, 
echocardiography might be 
useful to guide therapy
CO ↓, SVR ↓
Tachycardia, diminished 
pulses, with hypotension, 
hyperpnoea, altered 
mentation
Crytalloid boluses of 20 ml/kg 
repeat until hemodynamics 
stable, early inotropic 
support with dopamine or 
epinephrine might be required, 
echocardiography might be 
useful to guide therapy
Obstructive
Preload ↓, CO ↓, SVR normal 
to ↑
Tachycardia, hypotension, 
JVD, tracheal deviation if 
pneumothorax, equalization of 
pressures with elevated CVP if 
invasive monitoring in place
Rapidly fatal if underlying 
process not recognized and 
reversed, fluid boluses should 
be given while preparation is 
made for emergent drainage
Table 1. Types of shock seen in pediatric patients. CO = cardiac output, SVR= systemic vascular resistance, 




This is by far the most common type of 
shock seen in pediatric patients. Hypo-
volemia may be absolute with actual 
fluid losses (severe dehydration with 
gastrointestinal losses, renal losses in 
diabetes mellitus, etc) or frank loss of 
blood as in hemorrhagic shock. Non-
hemorrhagic hypovolemic shock is the 
most common type seen in the devel-
oping world. Findings of dehydration 
are present on physical exam with dry 
mucous membranes, sunken eyes and 
fontanels, diminished skin turgor (table 
1). (10) Table 2 summarizes the varying 
presentation of hemorrhagic shock in 
children based on blood loss.
Distributive Shock
Volume loss could also be relative - 
sometimes referred to as distributive 
shock seen in anaphylaxis or spinal 
shock. The mechanism involved here 
is not an absolute loss of intravascu-
lar volume but pathological and inap-
propriate vasodilatation, endothelial 
dysfunction with capillary leak, loss of 
vascular tone or a combination of 
these factors. Based on the underly-
ing etiology intravascular fluid volume 
is “maldistributed” and signs of shock 
will appear. In septic and anaphylactic 
shock, intravascular fluid leaks into the 
interstitial space augmenting the hypo-
volemic state.
Septic shock
Sepsis remains a major cause of mortal-
ity and morbidity for children. Although 
mortality from pediatric sepsis and sep-
sis shock has decreased from over 95% 
in 1960s to nearly 10% in 1990s, data 
from a recent US survey suggests that 
more than 4,300 children die each year 
from severe sepsis and septic shock 








































Table 3. Mechanisms of action, therapeutic effects and common doses of the most frequently used inotropic and 
vasoactive agents (mcg, micrograms, mU, miliunits).
















Nitroprusside NO donor, smooth muscle relaxation Vasodilatation 0.5-10 mcg/kg/min
Vasopressin V1 vascular receptors vasoconstriction 0.3-4 mU/kg/min
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and the annual cost is approximately $ 
2 billion. (11)     
Definitions for pediatric systemic inflam-
matory response syndrome, sepsis, 
severe sepsis and septic shock were 
standardized at the international con-
sensus conference in 2002. (12) Chil-
dren have specific physiological chang-
es that occur as part of normal growth 
and development. Normal values for 
vital signs and laboratory values are also 
age dependant. Accordingly, for the pur-
poses of diagnosing sepsis syndromes, 
pediatric patients are divided into six 
different age groups (neonate, newborn, 
toddler, child and adolescent). Accord-
ing to the international consensus cri-
teria systemic inflammatory response 
syndrome (SIRS) is defined as tachycar-
dia or tachypnea with fever or high leu-
kocyte count. Sepsis is defined as SIRS 
in the presence of suspected or proven 
infection; and severe sepsis is defined 
as sepsis with accompanying organ 
dysfunction. When cardiovascular fail-
ure occurs in the setting of severe sep-
sis then it is classified as septic shock. 
The consensus definition also provides 
specific criteria for diagnosis of organ 
dysfunction (respiratory, cardiovascu-
lar, hematologic, neurologic, renal, and 
hepatic). In adults the classic picture of 
septic shock is one of high cardiac out-
put and low SVR (warm shock). (13,14) 
However pediatric vascular tone is 
maintained in septic shock (6,7,15) and 
sepsis-induced myocardial dysfunction 
is more common. Therefore, pediatric 
septic shock can occur as low CO/high 
SVR, high CO/low SVR, or low CO/low 
SVR.  In fact, in one study where cardiac 
index was measured, the majority (80%) 
of septic shock cases had low cardiac 
index and only about 20% presented 
in the typical “warm shock” (bounding 
peripheral pulses and flash capillary 
refill). (7) This has important therapeu-
tic implications as children have more 
myocardial dysfunction in the setting 
of septic shock compared to adults 
and might benefit from early inotropic 
support and even in some instances 
afterload reduction. In adults the abil-
ity to increase oxygen consumption as 
oxygen delivery is enhanced by clinical 
interventions is associated with better 
survival in septic shock. (16) No evi-
dence in pediatrics exists that oxygen 
extraction decreases in septic shock. 
In children with septic or cardiogenic 
shock, the major determinant for oxy-
gen consumption is oxygen delivery, 
not oxygen extraction (15); therefore, 
efforts should be aimed at improving 
CO and oxygen delivery. 
Cardiogenic shock
This type of shock is simply a pump 
failure. Myocardial failure may be pri-
mary as in myocarditis, congenital heart 
disease or secondary as in myocar-
dial dysfunction in the setting of toxins, 
ischemia. Early use of echocardiogra-
phy should be considered. Judicious 
fluid administration might still be indi-
cated as many patients might still be 
on the hypovolemic side with room 
on theirs Starling curve. However, the 
mainstay of treatment is pharmacologi-
cal support of the failing myocardium. 
Extracorporeal therapies are increas-
ingly being used as a bridge to trans-
portation or to “rest” the myocardium 
to allow recovery. 
Obstructive shock
This is the setting of circulatory defi-
ciency where venous blood return to the 
heart (preload) is “obstructed” usually 
as a result of an intrathoracic catastro-
phe such as tension pneumothorax or 
cardiac tamponade.
Diagnosis
It is important to reiterate that recogni-
tion of early shock in children could be 
difficult and requires maintaining a high 
index of suspicion by the clinician and 
a focused clinical exam. Physical exam 
should be directed at detecting signs 
of tissue hypoperfusion such as altered 
mental status, irritability, tachypnea, 
tachycardia, cold mottled extremities, 
prolonged capillary refill. For pediatric 
patients, a normal blood pressure in 
and by itself should not be used as a 
marker  for adequate hemodynamics 
since hypotension is a sign of uncom-
pensated shock and occurs late in the 
cascade. 
While a focused clinical examination 
is a must, there are several aspects in 
the history that require special atten-
tion. Questions should be directed at 
preexisting chronic illnesses, current or 
recent use of medications (especially 
immunosuppressants such as ster-
oids), use of illicit substances, prior and 
recent surgical procedures. The host 
factor is especially important in certain 
conditions of congenital or acquired 
immune deficiency, indwelling cath-
eters, congenital heart disease all of 
which will require case-specific assess-
ment and treatment. 
Treatment
Early recognition and timely interven-
tion are critical in treating shock and 
preventing progression of the shock 
cascade. Furthermore, early goal 
directed therapy has been shown to 
decrease mortality in adults and chil-
dren. (17) In infants and children a 9 
fold improvement in survival rate was 
achieved when aggressive resuscita-
tion was initiated early by the emer-
gency room physician. (4) 
The goal of resuscitation is to reverse 
circulatory insufficiency and correct the 
hypoperfusion state. Animal studies 
have shown that early fluid resuscita-
tion improves tissue ATP levels in burn 
shock. (18) Figure 2. summarize the 
clinical practice guidelines for man-
agement of children with septic shock 
developed by the American College 
of Critical Care Medicine Task Force 
on Pediatrics. These guidelines could 
essentially be applied to the manage-
ment of all kinds of pediatric shock . 
(19) Neonates are considered sepa-
rately since there are several unique 
clinical entities and physiological con-
siderations like ductal-dependent con-
genital heart diseases and pulmonary 
hypertension that accompanies most 
shock states. The management guide-
lines for neonates are presented in 
Figure 3. 
The first step in clinical management is 
always ABCs. Airway is the first prior-
ity and may need to be protected or a 
definitive airway established particularly 
in children with altered mental status. 
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Figure 2. Recommendations for management of infants and children with 
septic shock (reprinted with permission). (19)
Since functional residual capacity is 
smaller in pediatric patients compared 
to adults, early assisted ventilation 
might be required. In addition, endotra-
cheal intubation may be indicated for 
hemodynamic instability alone since 
taking over the work of breathing will 
decrease oxygen consumption sub-
stantially. Care must be taken in select-
ing the appropriate induction agent for 
controlled pharmacological intubation 
to avoid hypotension and myocardial 
depression. While etomidate is not rec-
ommended in septic shock because of 
associated adrenal suppression, keta-
mine may be a reasonable choice in 
these cases. (20) Regardless of the 
agent used, initiation of positive pres-
sure ventilation will decrease venous 
return and cause hypotension in the 
volume depleted patient. Therefore, 
aggressive fluid resuscitation should 
begin almost simultaneously with airway 
management. Following Frank-Star-
ling mechanism, as left ventricular end 
diastolic volume increases stroke vol-
ume will increase proportionately. Fluid 
resuscitation is the first-line treatment 
in all shock syndromes. Mortality is sig-
nificantly decreased when children with 
septic shock early liberal fluid resus-
citated compared to those who were 
volume restricted. (21-23) Large bore 
intravenous or failing that intraosseous 
access should be established rapidly. 
The choice of resuscitation fluid–crys-
talloid vs. colloid- has been debated 
for many years. (24) Data from pediatric 
studies are scarce. Colloid solutions 
effectively restore blood pressure espe-
cially in young neonates (9); however, 
there is a concern over the potential 
adverse effects of using natural and 
synthetic colloids (disease transmis-
sion/exposure, allergic reactions). In 
adults a recent randomized controlled 
clinical trial (25) comparing crystalloid 
to colloid in resuscitation demonstrated 
no benefit or adverse effects of using 
either solution. In a recent pediatric 
open-label trial children with septic 
shock were randomized to receive 
either normal saline or gelatin polymer 
in saline. Both groups achieved hemo-
dynamic stability and mortality and 
organ failure rates were similar in both 
groups. The colloid resuscitated group 
required 40% less volume compared to 
the saline resuscitated group. (26) In 
postoperative cardiac surgery patients 
where volume load is a concern, the 
use of hypertonic solutions might be 
beneficial. (27) The critical component 
seems to be not the type of fluid chosen 
but the time period of resuscitation. 
Early fluid resuscitation should always 
be liberal. In children with dengue fever 
shock, aggressive fluid resuscitation in 
the first hour targeting normalization of 
heart rate, hematocrite and resolution 
of narrow pulse pressure was associ-
ated with 100% survival regardless of 
the type of fluid used. (22,28) In general 
isotonic saline is efficacious, safe and 
more cost effective compared to col-
loids and should be the fluid of choice 
during the initial resuscitation. (25) The 
first fluid bolus should be 10-20 ml/kg 
and further fluid administration should 
be individualized based on continual 
assessment of the clinical presentation 
and response to treatment. (19,21,29) 
As the fluid given as bolus is redis-
tributed, only 25% of crystalloid solu-
tions will remain in the intravascular 
compartment and 75% diffuses into the 
interstitial space. This excess fluid in the 
interstitial compartment will contribute 
to the development of edema and fluid 
overload which has been implicated as 
a mortality risk factor in certain popula-
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Figure 3.  Recommendations for management of neonates with septic shock 
(reprinted with permission). (19) 
tions of critically ill children. (30) The 
relatively short lifespan of intravascu-
lar crystalloids has led to investigating 
the use of hypertonic saline in trauma, 
hemorrhagic shock and traumatic brain 
injury. (31,32) There is circumstantial 
evidence that albumin administra-
tion in these cases is associated with 
increased mortality. (25,33,34) 
Shock related mortality is independent 
of maintaining or normalizing the blood 
pressure alone, but is directly related 
to low cardiac index and low mixed 
venous oxygen saturations  (21). Trans-
fer to a tertiary care pediatric facility or a 
pediatric intensive care unit is strongly 
recommended for children in septic 
shock. (35) 
Fluid Refractory Shock-time 
for more support
Goal directed therapies target mixed 
venous or superior venous cava oxy-
gen saturation of > 70 % and normal 
perfusion pressure. While perfusion 
pressure (CO= MAP-CVP/SVR) should 
be maintained in a normal range to 
ensures adequate organ function, 
continuous reassessment during fluid 
resuscitation is critical to avoid over 
resuscitation and evaluate responsive-
ness. In patients with inadequate or 
no response to fluids, fluid refractory 
shock (Figures 2, 3), pharmacological 
support using vasoactive amines is 
necessary. A comparison of ionotropes 
and vasopressor commonly used in 
the clinical setting is presented in table 
3. The choice of appropriate agent 
depends on clinical findings such as 
cold or warm shock. However, warm 
shock (bounding peripheral pulses and 
flash capillary refill) is infrequent in pedi-
atric septic shock. Children have pro-
gressive myocardial dysfunction and 
the majority of septic children is hypo 
dynamically unstable and requires ino-
tropic support. (7) Central venous cath-
eter access is usually recommended 
in these cases to gauge response to 
therapy and monitor central venous 
pressure.
Choice of pressors
 The vasoactive agent of choice in 
pediatric patients is dopamine. For 
dopamine refractory cold shock, epine-
phrine is the recommended second 
line agent. (19) However, when low 
mixed venous oxygen saturation and 
myocardial dysfunction is suspected, 
dobutamine is more appropriate for 
improving cardiac index and decreas-
ing afterload. (36) Dobutamine has also 
been suggested to reverse microcircu-
latory abnormalities that might persist 
despite normalization of blood pres-
sure and achievement of stable hemo-
dynamics. (37) 
In adult septic shock, vasopression lev-
els are low and this finding is thought to 
contribute to vasodilatation. (38) While 
this finding is not consistently noted in 
children (39,40), vasopressin has been 
shown to improve hemodynamics in 
neonates with post-cardiopulmonary 
bypass vasodilatatory shock. (41) Use 
of vasopressin in other types of shock 
is still controversial but might be con-
sidered as rescue therapy in refractory 
hypotension as an adjuvant to existing 
inotropes. (42)
For nonresponders to vasoactive age-
nts, sepsis-related insensitivity to ß-
adrenergic stimulation was described 
in adult sepsis. (43) Phosphodieste-
rase (PDE) inhibitors like milrinone and 
enoximone increase cAMP independent 
of the ß-receptor pathway by inhibiting 
break-down and thereby having ino-
tropic, lusitropic and vasodilator proper-
ties. Milrinone particularly it has been 
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shown to be particularly useful in the 
setting of cardiogenic shock. In children 
with septic shock systolic function is 
decreased and afterload is increased. 
(8) Ventricular dilatation is not observed 
in pediatric septic shock compared to 
adult septic shock. With depressed 
myocardial contractility, compensation 
by increasing SVR is actually detrimen-
tal and overtaxes the already strained 
heart. In cases of low CO cold shock, 
afterload reduction with volume loading 
to maintain preload might improve CO 
and tissue perfusion. In children with 
cold septic shock (sepsis induced myo-
cardial dysfunction) milrinone improved 
cardiac index, LVSWI, and oxygen deliv-
ery and decreased SVR and PVR. (44) 
In animal sepsis models, PDE inhibitors 
have been shown to decrease release 
of several proinflammatory mediators, 
decrease nitric oxide synthase activity 
and improve myocyte function. (44,45) 
Left ventricle failure complicates fluid 
refractory shock. (46) Therefore, another 
option in cold shock could be combina-
tion therapy with epinephrine to increase 
contractility and a vasodilator like nitro-
prusside to decrease SVR, however, this 
approach would require caution since 
nonselective venous vasodilatation 
caused by nitroprusside might lead to 
hypotension. In warm shock, the agent 
of choice will be norepinephrine. How-
ever caution should be exerted while 
using this potent agent in the setting 
of myocardial dysfunction since it does 
have some inotropic and chronotropic 
properties and might cause unwanted 
stress on the affected myocardium by 
causing endocardial ischemia. 
For catecholamine refractory-shock the 
use of extracorporeal membrane oxy-
genation (ECMO) could be considered. 
Survival rates of over 60% are reported 
in catecholamine refractory pediatric 
septic shock with the use of ECMO. (47) 
However, for this complicated treatment 
that requires a team-effort to succeed, 
the particular center should be well-
versed in ECMO with up-to-date train-
ings of all team members. In a recent 
pediatric report, dramatic improvement 
in survival rates was reported when 
rescue ECMO was used as extracar-
diac life support (ECLS) in in-house 
pediatric cardiac arrests. Other extra-
corporeal treatments like high-volume 
hemofiltration and plasmapheresis are 
suggested to improve hemodynamics 
and mortality by removing cytokines in 
adults (48,49),  limited pediatric data 
exist but is promising in a subset of 
critically ill children with multi-organ 
dysfunction. (50)
Follow-up of response to 
treatment
The most sensitive indicator of ade-
quate cardiac output in children is 
the heart rate. Treatment should be 
modified as necessary based on moni-
tored vital signs, exam findings and 
laboratory values. The earliest sign of 
reversal of shock is usually a decline in 
heart rate followed by improved blood 
pressure and increased urine output. 
The goals should be normalization of 
capillary refill (< 2 seconds), normal 
peripheral pulses, warm extremities, 
adequate urine output of greater than 
1ml/kg/hr, normal mental status. Blood 
pressure itself is not a reliable endpoint 
of resuscitation but an improvement in 
the HR/SBP ratio - also called the shock 
index- can be used as an indicator of 
improving perfusion. In an intubated 
patient with an indwelling arterial cathe-
ter for invasive blood pressure monitor-
ing, intravascular volume depletion will 
manifest as respiratory variation in the 
arterial line tracing. With each positive 
pressure breath, intrathoracic pressure 
will increase; the venous return to the 
heart will decrease in turn decreasing 
the stroke volume. With volume loading, 
this variation will disappear. 
Serum pH, lactate, base deficit and 
bicarbonate are well demonstrated 
surrogate markers of tissue perfusion 
that correlate with severity of shock 
and adequacy of resuscitation in adult 
patients and are proven to be even 
more useful than estimated blood loss, 
heart rate and blood pressure (conven-
tionally recorded hemodynamic meas-
urements). (51,52) Serum glucose and 
calcium levels should be checked and 
abnormalities should be corrected. 
Normalization of serum bicarbonate 
and lactate are associated with patient 
recovery in pediatric septic shock. 
(53) Successful resuscitation should 
be accompanied by a decreasing anion 
gap, decreasing lactate and improv-
ing base excess. In patients with fluid 
refractory shock a central line in a cen-
tral venous pressure monitor position 
should be in place and a mixed venous 
oxygen saturation or central venous 
oxygen saturations of > 70% should be 
targeted. Because children with septic 
shock die of low oxygen delivery and 
cardiac output, the superior vena cava 
or mixed venous saturation is suggest-
ed as the fifth vital sign of intensive care. 
(54,55) Low venous saturations can be 
corrected by increasing hemoglobin 
concentration or by increasing cardiac 
output. 
Can we give too much 
fluid?
Continuous assessment and close bed-
side monitoring and intervention are 
the key to successful resuscitation in 
pediatric shock. For example, when 
hemodynamic parameters are worse 
with fluid resuscitation and signs of con-
gestive heart failure become apparent 
the addition of inotropic agents may be 
warranted. In a study of over 35 children, 
Carcillo et al did not find a difference 
in the occurrence of ARDS between 
groups with restricted fluid resuscita-
tion compared to those who received 
liberal fluid resuscitation. Complica-
tions from over resuscitation could be 
abdominal compartment syndrome, 
ARDS, and organ failure. However, in 
a study of over 35 children, Carcillo et 
al did not find a difference in the occur-
rence of ARDS between groups with 
limited resuscitation vs. those with a 
liberal fluid regimen. Therapy should 
be guided not by the absolute numbers 
of volume of fluid administered but by 
improving physical exam findings. While 
early aggressive treatment is warranted, 
there is evidence that fluid overload is 
a mortality predictor independent of 
severity of illness in critically ill children. 
Early institution of renal replacement 
therapies should be considered after 
the initial instability resolves to ensure 
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metabolic control and allow for ade-
quate nutrient delivery. (54) 
Antibiotics and Infection 
Source Control
Surviving Sepsis Guidelines proposed 
by an international consensus of criti-
cal care organizations to raise aware-
ness about and improve outcomes 
from sepsis, recommend commencing 
early broad-spectrum antibiotic ther-
apy as soon as appropriate cultures 
are obtained in suspected sepsis. (56) 
Early administration of antibiotics has 
been shown to improve survival in multi-
ple trials. (57,58) The choice of the initial 
antibiotic combination should be direct-
ed by specific host factors, underlying 
illnesses and site of suspected infection 
as well as antibiotic resistance patterns 
in the community and ICU. Antibiotics 
should be reevaluated as soon as cul-
ture results and susceptibilities are avail-
able in order to narrow the spectrum in 
an attempt to avoid emergence of mul-
tiple-drug resistance. In some cases of 
localized infection such as deep tissue 
abscess or intra abdominal infections, 
sole reliance on antibiotic treatment 
is not enough and measures should 
be directed early to control source of 
infection. The methods involved might 
range from minimally-invasive abscess 
drainage by interventional radiology to 
open surgery. 
Steroid Use in Pediatric 
Shock 
Relative adrenal insufficiency is com-
mon in the PICU, occurring in over 75% 
of patients in septic shock. (59) Nonre-
sponders -patients who fail to increase 
serum cortisol levels in response to 
test-dose corticotrophin - have 60% 
mortality compared to responders. 
There is evidence in adult patients with 
septic shock that low-dose steroids 
shorten shock duration. (60) No sup-
porting data is available for the pediat-
ric population. The recent CORTICUS 
study found that in adult critically ill 
patients treatment with steroids did 
not have a survival benefit and was 
associated with increased incidence of 
nosocomial infections. (20) In the light 
of these findings, routine treatment of 
pediatric patients with steroids cannot 
be recommended. However in children 
with catecholamine-refractory shock or 
in the presence of risk factors such as 
history of chronic or recent high dose 
steroid treatment, steroid administra-
tion should be considered. (19) 
Conclusion
Pediatric shock syndrome is treatable if 
recognized early. Successful manage-
ment requires early aggressive fluid 
resuscitation followed by treatment indi-
vidualization based on bedside assess-
ment. Support should escalate rapidly 
following American College of Critical 
Care task force guidelines. Life sav-
ing interventions do not require state-
of-the-art medical technology, can be 
instituted by primary care physicians 
and lead to dramatic improvement in 
survival.
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